These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 19453367)
1. Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival. Krick EL; Billings AP; Shofer FS; Watanabe S; Sorenmo KU Vet Comp Oncol; 2009 Jun; 7(2):130-8. PubMed ID: 19453367 [TBL] [Abstract][Full Text] [Related]
2. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases. Taylor F; Gear R; Hoather T; Dobson J J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421 [TBL] [Abstract][Full Text] [Related]
3. Correlation of nodal mast cells with clinical outcome in dogs with mast cell tumour and a proposed classification system for the evaluation of node metastasis. Weishaar KM; Thamm DH; Worley DR; Kamstock DA J Comp Pathol; 2014 Nov; 151(4):329-38. PubMed ID: 25172053 [TBL] [Abstract][Full Text] [Related]
4. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours. Kiupel M; Webster JD; Miller RA; Kaneene JB J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909 [TBL] [Abstract][Full Text] [Related]
5. Outcomes of dogs with grade 3 mast cell tumors: 43 cases (1997-2007). Hume CT; Kiupel M; Rigatti L; Shofer FS; Skorupski KA; Sorenmo KU J Am Anim Hosp Assoc; 2011; 47(1):37-44. PubMed ID: 21164163 [TBL] [Abstract][Full Text] [Related]
6. A review of sentinel lymph node evaluation and the need for its incorporation into veterinary oncology. Tuohy JL; Milgram J; Worley DR; Dernell WS Vet Comp Oncol; 2009 Jun; 7(2):81-91. PubMed ID: 19453362 [TBL] [Abstract][Full Text] [Related]
7. Characterisation of the signalment, clinical and survival characteristics of 41 cats with mast cell neoplasia. Litster AL; Sorenmo KU J Feline Med Surg; 2006 Jun; 8(3):177-83. PubMed ID: 16476559 [TBL] [Abstract][Full Text] [Related]
8. Effects of stage and number of tumours on prognosis of dogs with cutaneous mast cell tumours. Murphy S; Sparkes AH; Blunden AS; Brearley MJ; Smith KC Vet Rec; 2006 Mar; 158(9):287-91. PubMed ID: 16517820 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs. Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187 [TBL] [Abstract][Full Text] [Related]
10. Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures. Worley DR Vet Comp Oncol; 2014 Sep; 12(3):215-26. PubMed ID: 22958227 [TBL] [Abstract][Full Text] [Related]
11. Association of histologic tumor characteristics and size of surgical margins with clinical outcome after surgical removal of cutaneous mast cell tumors in dogs. Schultheiss PC; Gardiner DW; Rao S; Olea-Popelka F; Tuohy JL J Am Vet Med Assoc; 2011 Jun; 238(11):1464-9. PubMed ID: 21627510 [TBL] [Abstract][Full Text] [Related]
12. Lymph node histology for the assessment of residual neoplastic disease in canine mast cell tumours: does the presence of metachromatic granules always identify mast cells? Ressel L; Finotello R Vet Comp Oncol; 2017 Dec; 15(4):1119-1121. PubMed ID: 27714908 [No Abstract] [Full Text] [Related]
13. Evaluation of prognostic factors for dogs with primary lung tumors: 67 cases (1985-1992). McNiel EA; Ogilvie GK; Powers BE; Hutchison JM; Salman MD; Withrow SJ J Am Vet Med Assoc; 1997 Dec; 211(11):1422-7. PubMed ID: 9394893 [TBL] [Abstract][Full Text] [Related]
14. Use of indirect computed tomography lymphangiography to determine metastatic status of sentinel lymph nodes in dogs with a pre-operative diagnosis of melanoma or mast cell tumour. Grimes JA; Secrest SA; Wallace ML; Laver T; Schmiedt CW Vet Comp Oncol; 2020 Dec; 18(4):818-824. PubMed ID: 32216019 [TBL] [Abstract][Full Text] [Related]
15. Advances in the diagnosis and management of cutaneous mast cell tumours in dogs. Dobson JM; Scase TJ J Small Anim Pract; 2007 Aug; 48(8):424-31. PubMed ID: 17559522 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. Abadie JJ; Amardeilh MA; Delverdier ME J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425 [TBL] [Abstract][Full Text] [Related]
17. Surgical approach for lymph node staging of oral and maxillofacial neoplasms in dogs. Smith MM J Vet Dent; 2002 Sep; 19(3):170-4. PubMed ID: 12382534 [No Abstract] [Full Text] [Related]
18. Nucleomorphometric analysis of canine cutaneous mast cell tumours. Maiolino P; Cataldi M; Paciello O; Restucci B; De Vico G J Comp Pathol; 2005; 133(2-3):209-11. PubMed ID: 16045919 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors. Hahn KA; Legendre AM; Shaw NG; Phillips B; Ogilvie GK; Prescott DM; Atwater SW; Carreras JK; Lana SE; Ladue T; Rusk A; Kinet JP; Dubreuil P; Moussy A; Hermine O Am J Vet Res; 2010 Nov; 71(11):1354-61. PubMed ID: 21034327 [TBL] [Abstract][Full Text] [Related]
20. Histologically low-grade, yet biologically high-grade, canine cutaneous mast cell tumours: A systematic review and meta-analysis of individual participant data. Bae S; Milovancev M; Bartels C; Irvin VL; Tuohy JL; Townsend KL; Leeper H Vet Comp Oncol; 2020 Dec; 18(4):580-589. PubMed ID: 32103587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]